Page 2 - Shilpa Medicare
Shilpa Medicare slips 5% as USFDA issues Form 483 for Telangana facility
The stock price has more than doubled in the past one month, from the level of Rs 260 on January 24, 2020
 "Shilpa Medicare slips 5% as USFDA issues Form 483 for Telangana facility")
Shilpa Medicare hits fresh 52-week high; stock zooms 89% in a month
The company's Ebitda margin expanded by 1,550 basis points to 32.1 per cent in Q3FY20 from 16.6 per cent in Q3FY19
 "Shilpa Medicare hits fresh 52-week high; stock zooms 89% in a month")
Shilpa Medicare tanks 36% in 10 days, hits 5-yr low on weak Q1 results
For Q1FY20, the company reported 55 per cent year-on-year (YoY) drop in its consolidated net profit at Rs 15 crore, due to lower sales
 "Shilpa Medicare tanks 36% in 10 days, hits 5-yr low on weak Q1 results")
Shilpa Medicare surges 13% after receiving EIR from USFDA
The stock surged 13% to Rs 434 on the BSE in morning trade after the company said it has received EIR from the US health regulator for it's both facilities located at Raichur, Karnataka.
 "Shilpa Medicare surges 13% after receiving EIR from USFDA")
Shilpa Medicare gains 7% on EIR for Jadcherla formulations unit
The stock was 7% to Rs 488 on the BSE after the company received EIR from the USFDA for its formulation manufacturing facility in Telangana following the audit in November last year.
 "Shilpa Medicare gains 7% on EIR for Jadcherla formulations unit")
Shilpa Medicare slips after USFDA issues 10 observations
The stock slipped 6% to Rs 599 on the BSE in intra-day trade.
 "Shilpa Medicare slips after USFDA issues 10 observations")
Shilpa Medicare hits new high; stock up 35% in one month
The stock moved higher to its new high of Rs 746, up 3.5%, extending its 14% rally in past five trading sessions on BSE.
 "Shilpa Medicare hits new high; stock up 35% in one month")
Shilpa Medicare hits record high on strong Q2 results
The stock moved higher to its record high of Rs 679, up 9%, extending its Friday's 9% surge on BSE.
 "Shilpa Medicare hits record high on strong Q2 results")
Shilpa Medicare surges on USFDA nod for Jadcherla unit
The stock moved higher by 9% to Rs 612 on the BSE.
Shilpa Medicare rallies on getting GMP compliance certificate
The stock rallied 13% to Rs 493 on the BSE in early morning trade.
 "Shilpa Medicare rallies on getting GMP compliance certificate")
